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Abstract
Minimally invasive surgery has experienced a significant expansion in the 
last decades. Robotic surgery has evolved in parallel to traditional laparoscopic 
surgery offering additional technical advantages. Some specific aspect of 
Hepatobiliary Surgery led to a limited implementation of minimally invasive liver 
surgery in the early years of laparoscopic surgery whilst we are experiencing an 
exponential increase in the use of minimally invasive approaches to this type of 
intervention. In this chapter we describe the key aspect of robotic liver surgery 
with a meticulous description of the supporting evidence, its limitation and 
future perspectives.
Keywords: robotic surgery, robotic liver resection, hepatectomy,  
minimally invasive surgery, laparoscopic liver surgery
1. Introduction
Hepatic resection is the gold standard treatment for some of the most common 
malignant tumours of the liver, including primary tumours (hepatocellular carci-
noma and cholangiocarcinoma) and colorectal liver metastasis and it can be some-
times the treatment option for some benign tumours [1]. Hepatobiliary surgery also 
includes complex biliary interventions for benign and malignant pathologies that, in 
addition to the liver resection, may require biliary reconstructions and bilioenteric 
anastomosis [2].
Open surgery remains the predominant approach for most of these hepatobiliary 
procedures. However, there is an exponential increase of minimally invasive surgery 
(MIS) within this field, supported by large cases series and randomised control 
trials (RCTs) recently published in the literature [3].
Outcomes from the available literature suggests that MIS for liver resections 
improves patients’ outcomes in terms of length of stay, blood loss and postopera-
tive complications. Although some series suggest longer operative time and higher 
initial costs, the overall cost-efficiency seems to favour laparoscopic surgery  
[4, 5]. Despite this data, laparoscopic liver surgery is not routinely performed in all 
Hepatobiliary Centres and there is a large proportion of patients being treated via 
open approach. The delayed implementation of this type of intervention is com-
monly related to the technical challenges of these operations, the long tradition 
of open surgery associated to liver transplantation and the specific technological 
requirements attached to this type of resections.
From the original era of the pioneers in laparoscopic surgery, the consensus 
meetings in Louisville and Morikawa highlighted the challenges of this new 
approach. Recommendations from these meetings were very cautious about sug-
gesting laparoscopic liver surgery for every patient and limited its clear indication to 
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minor resections. From them, MIS for minor liver resections (less than 3 segments) 
such as left lateral secitonectomy and segmentectomies from the anterior Couinaud 
segments (II to VI) became well established [6]. On the contrary, there has been 
limited diffusion of minimally invasive major hepatectomies and it is commonly 
confined to high volume specialised centres [7]. This is in part due to the more 
complex anatomical and technical challenges of major hepatic resections, and the 
inherent limitations of laparoscopic surgery.
Traditional laparoscopic surgery is the most commonly used MIS technique 
for liver resections whilst there is also an increment in the number of series 
of robotic liver surgery [8]. Advantages of robotic surgery when compared to 
traditional laparoscopic surgery are well described and include: a magnified three 
dimensional (3D) view, tremor filtration and improved dexterity with articulated 
instruments providing seven degrees of freedom [9]. It also adds some surgeon’s 
specific advantages in terms of ergonomics with the suggested, but not proven, 
potential reduction of fatigue, increase precision and longer work expectancy. 
However controversies around robotic surgery remain when compared with 
laparoscopic surgery. Main limitation was always the higher cost without any 
evidence suggesting clinical superiority when compared to laparoscopic surgery. 
There is, in fact to date, lack of agreement whether they should be compared 
against each other, or directly compared to open surgery. We are of the opinion 
that both should be grouped as MIS and promoted equally for the benefit of the 
patient.
In this chapter we describe the key aspects of robotic hepatobiliary surgery, 
with a focus on technical descriptions, the current evidence base, limitations, and 
possible future developments.
2. Technique
Robotic liver surgery has probably evolved from laparoscopic liver surgery and 
therefore it is easy to find some similarities. It is however a very different interven-
tion, specially around the economy of movements, and it will vary significantly 
between centres and surgeons. Local expertise, surgeon’s preferences and patient’s 
specific conditions may modify the standard approach but there are some com-
mon principles. It is important to mention that currently all reported series have 
performed this type of intervention with the platform Da Vinci Robot from 
INTUITIVE® and some of the described technical aspect may apply only to this 
robotic system. New development of alternative robotic system may bring different 
technical concepts but the principles will prevail.
2.1 Set up and docking
There is significant overlap in the patient positioning, set up and operative tech-
nique between laparoscopic and robotic liver resections. This is commonly decided 
by the operating surgeon and based on his/her preferences. The main difference 
for a robotic approach is around port placement and the position of the “bed-side”/
assisting surgeon. It is essential to consider instrument clashing when deciding port 
placement. Alternatives to patient’s position include supine (with or without split 
legs) or left prone position. The latter is the preferred position in some centres to 
intervene in right posterior segments. Ports position in laparoscopic surgery is more 
versatile whilst robotic surgery demands wider space between trocars without any 






Patient (supine with split legs in a 15-0 degree reverse Trendelenburg) & assistant (between legs) positioning 
commonly utilised for major robotic hepatectomy. Subsequent camera and port placement depends on type of 
resection (Figures 2 and 3).
Figure 3. 
Patient positioning (left lateral decubitus) & port placement for robotic partial hepatectomy of postero-
superior segments. Rc, Robotic Camera Port; Ap, Assistant port (12mm); R1-3, Robotic ports (8-10 mm); 1, 
transpyloric plane; 2, intertubercular plane.
Figure 2. 
Port placement for robotic major hepatectomy.
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Following patient positioning and port insertion, the robotic cart is positioned 
within the surgical field and the arms docked. Traditional bed-side units are placed 
cephalic to the surgical field for most hepatobiliary and upper gastro-intestinal 
procedures. Newer versions allow the cart to be docked sideways to the patient. This 
adds the benefit of better access to the patient’s airway for the anaesthetic team. 
Irrespective of the system, close collaboration with the anaesthetist is essential at 
the time of docking.
2.2 Liver mobilisation
Following successful docking, the procedural steps are the same as for any 
hepatic resection and depend on the nature of the required procedure. Liver mobili-
sation is typically the first step and can be performed utilising a combination of a 
diathermy or an alternative energy device. For full mobilisation, all liver ligaments 
(Round/Falciform, Coronary and Triangular) need to be transected. Limited resec-
tions however, would not require full mobilisation. Traction and counter traction 
through lifting of the required liver lobes is provided with the combination of 
retractors and changes in the patient’s position. This requires special attention if the 
operating table’s movement are not linked to the robotic cart. New docking might 
be required. Lack of tactic feedback can lead to underestimation of the pressure 
applied to the liver with the consequent capsular tear. Alternatives will include a 
laparoscopic liver retractor manipulated by the bed side surgeon. Similarly, intraop-
erative ultrasound can be performed at this point with the close collaboration of the 
console and bed side surgeons.
2.3 Hilar dissection and hepatoduodenal clamping
Robotic surgery can overcome the limitations of laparoscopic surgery during 
complex hilar dissections, with the combination of 360 degrees angulation, 3D view 
and scaled movements providing significant advantages to the operator. The exact 
technicality of hilar dissection will again depend on the surgeon’s experience and 
preferences. Some centres will routinely establish a window in the lesser omentum 
and pass a sloop or tape to facilitate a Pringle manoeuvre. Similarly to traditional 
LLS, this can be performed purely intracorporeally or extracorporeally (exterior-
ization of the clamp/tourniquet via an accessory port). However the high volume 
specialist centres have suggested this is not routinely required during robotic 
hepatectomy [10–12].
2.4 Parenchymal transection
There are multiple techniques for parenchymal transection and they are widely 
modified to the personal preferences of the operating surgeon. Kellyclasia technique 
(clamp-crushing) is held as the current gold standard, although recent advances 
have focused on the introduction of open and laparoscopic energy devices aimed 
at reducing blood loss during parenchymal division [13]. This crucial part of the 
operation is viewed as one of the limiting factors in the diffusion of MIS for the liver 
across hepatobiliary centres. Whilst robotic surgery improves the suturing capacity 
and bleeding control in difficult circumstances, the lack of an equivalent robotic 
energy device may require a hybrid approach with the assisting surgeon performing 
laparoscopic parenchymal transection at the operating table using an appropriate 
energy device [14]. Based on this principle, traditional laparoscopic instruments 
and stapling devices can be used similarly to the traditional laparoscopic approach 





There is no difference between robotic and laparoscopic surgery at this point, 
with removal of the specimen via a retrieval bag is achieved following undocking of 
the robotic arms. Options for specimen extraction include extension of an existing 
port site or a new incision. There is little evidence comparing all available options 
but there seems to be a preference towards the Pfannestiel incision [15].
3. Current evidence
3.1 Major resections
Major hepatectomies (resection of 3 or more contiguous segments) and 
extended hepatectomies with bile duct resections are complex, challenging proce-
dures. High volume specialist centres have shown a minimally invasive approach to 
be feasible but the results from the only prospective randomised trial (ORANGE-II 
plus) are yet to be published [8, 10, 16]. At present, less than 10% of major liver 
resections are performed laparoscopically, largely due to the challenges posed by the 
location of the liver, its proximity to major vasculature and the difficulty in appre-
ciating the complex biliary and hepatic vascular anatomy during a laparoscopic 
procedure [17]. Utilising a robotic approach may negate these disadvantages, with 
improved views and dexterity facilitating a precise hilar and hepatocaval dissection, 
advanced suturing and easier biliary-enteric anastomosis.
Specialised centres have published favourable outcomes (Table 1) and a limited 
number of multi centre comparative studies have demonstrated positive results 
[18–21]. A recent review of outcomes from 584 major robotic liver resections dem-
onstrated acceptable blood loss, operation time, R0 resection rate, length of hos-
pital stay and post op morbidity. When directly compared to laparoscopy, robotic 
major hepatectomies demonstrated significantly improved rates of post-operative 














2011 27 RH (74%), 
LH (19%), 
RTS (7%)
3.7% 7 days 30% 0%
Choi et al. 2012 20 RH (30%), 
LH (70%)
10% 15 days 40% 0%
Spampinato 
et al.





4% 8 days 16% 0%
Fruscione 
et al.







Wang et al. 2019 92 RH (48%), 
LH (52%)
1% 7 days 13% 0%
RH, right hemi-hepatectomy; LH, left hemi-hepatectomy; RTS, right tri-sectionectomy; ERH, extended right hemi-
hepatectomy; LLS, left lateral secitonectomy; SgVII, segment 6. Morbidity rate, includes post op complications from 
Clavien Dindo grades I-V. Mortality rate, 30 day post-operative mortality.
Table 1. 
Published series focused on outcomes following robotic major hepatectomies in the literature.
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critical care admission, 90 day re-admission rate and a similar length of stay and 
complication rate [22].
The robotic approach has also been shown to be feasible for simultaneous 
resection of a colorectal primary malignancy and the associated liver metastasis. 
Analysis of a small number of major hepatic resection with synchronous colorectal 
resection, demonstrated robotic resection to have acceptable morbidity and onco-
logical outcomes [23].
The robotic approach has also been considered as an alternative to open surgery 
for hepatectomies requiring more extended resections and or biliary reconstruc-
tions. Outcomes published by 2 specialist centres demonstrated the robotic 
approach as a safe and feasible alternative to open surgery for hilar cholangiocarci-
noma. However whilst technically feasible and safe, the results did not demonstrate 
equivalence to open surgery. Indeed they reported longer operative times and a 
higher estimated blood loss relative to open surgery. Furthermore, robotic resec-
tion was associated with poorer oncological outcomes with a lower recurrence free 
survival rate [24, 25].
Given the relative infancy of robotic innovation within the field of minimally 
invasive surgery, it is perhaps unsurprising that the literature around major robotic 
liver surgery is somewhat limited. The utility of a laparoscopic approach to major 
hepatectomy is only presently under investigation and any advantages relative to 
open surgery remains unestablished. Within this context, it is unclear if open or 
laparoscopic surgery should be the standard against which robotic surgery is held. 
At present, level II and III evidence suggests that robotic surgery is safe, feasible, 
and certainly non inferior to laparoscopic or open surgery. However it remains 
uncertain if this will translate to clinically significant short and long term outcomes 
in larger, prospective studies.
3.2 Minor resections
Minor hepatic resections, a category encompassing non-anatomical wedge 
resections, left lateral sectionectomies, segmentectomies and bisegmentectomies, 
are the most commonly performed minimally invasive hepatic operative interven-
tions in both the laparoscopic and robotic settings [10, 17].
While the evidence discussed above suggests the multitude of technical advan-
tages as well as non-inferiority of the robotic approach to major hepatic resections, 
it is pertinent to critically examine the role of robotic surgery in minor resections if 
aiming to confer improved operative outcomes to the greatest number of patients.
In keeping with the increasing trend for parenchymal sparing liver resection, 
non-anatomical and anatomical wedge resections are the mostly commonly per-
formed robotic liver minor resection [10]. Indeed, a minimal access approach to 
resect only small amounts of hepatic tissue seems logical considering the morbidity 
associated with large abdominal incision; a position supported by international 
consensus in 2008 [26]. Particular difficulties exist, however, when performing 
laparoscopic in the postero-superior segments of the liver where a combination of 
the costal margin and rigidity of laparoscopic instruments conspire to make opera-
tive access difficult [12].
A number of robotic minor resection cases series from enthusiast centres report 
broadly equivalent operative times, operative blood loss and post-operative morbid-
ity without significant differences to laparoscopic approaches, although the techni-
cal benefit of the robotic endo-articulated wrists were repeatedly emphasised as a 
partial solution to the difficulties involved with postero-superior segment resec-
tions [10, 20, 27, 28]. Furthermore, the use of robotic tremor filtration and gain 




sparing surgery and finer hilar or hepato-caval dissection, technical feats which 
can be challenging in the laparoscopic setting, potentially reducing requirement for 
conversion to open [27, 29]. These studies are retrospective, and while some include 
propensity score matching, prospective randomised controlled trial data is lacking. 
Results from the Dutch ORANGE-SEGMENTS trial investigating the role of open 
vs. laparoscopic postero-superior liver segmental resection and results are awaited, 
but to date no such trials are ongoing in regard to robotic non-anatomical and 
anatomical wedge resections.
Left lateral sectionectomy consists of the resection of hepatic segments II and 
III. The minimally invasive approach has become standard of care for this minor 
resection with comparative ease of access to the left lateral section, a relatively 
distant relationship to major vasculature and often minimal difficult mobilisation 
requirement leading this hepatic resection to be considered one of the more straight 
forward minor hepatectomies [7].
A small number of retrospective studies have aimed to compare the laparoscopic 
to open approach in left lateral sectionectomy [30–32]. These studies compared a 
small number of robotic left lateral sectionectomies with retrospective laparoscopic 
approaches, finding broadly similar results, with no significant differences in 
operative blood loss, clinical outcomes or operative time, although increased opera-
tive costs. A further study, which examined a subgroup of more complex left lateral 
sectionectomy, with BMI >30, larger tumours or closure operative proximity to 
major vasculature, reported a significant reduction in operative blood loss, although 
no significant difference in the overall study group [33]. These results led authors to 
conclude that the laparoscopic approach to left lateral sectionectomy should remain 
the standard of care, although it is notable that while gold standard, the only ran-
domised controlled trial comparing laparoscopic vs. open left lateral sectionectomy, 
ORANGE-II, failed to show a significant difference in outcome when compared the 
laparoscopic to open approach to left lateral sectionectomy [34]. This result was, in 
part, due to premature trial cessation due to slow trial recruitment, perhaps reflect-
ing the board uptake of minimal access approach to left lateral sectionectomy. It 
remains possible that with evidence of clinical non-inferiority of robotics, enthusi-
astic uptake may further popularise the robotic approach in a similar fashion.
4. Oncological outcomes
Given that liver resections are predominantly carried out for malignant pathol-
ogy, oncological standards such as resection margins, lymph node yields, recur-
rence and disease free survival are the critical outcomes against which robotic 
hepatectomy should be evaluated. To that end, we have recently published a review 
of the literature and found robotic liver surgery to be equivalent with regards to the 
completeness of the resection margin (96% R0) [35]. Although there are a limited 
number of studies reporting longer term oncological outcomes such as recurrence 
and disease free survival, the results so far have been promising.
4.1 Hepatocellular carcinoma (HCC)
HCC is the predominant malignancy for which a robotic approach has been 
utilised, with 40% of the cases published in the literature indicating this as the 
underlying indication [22]. Three studies have examined the longer term oncologi-
cal outcomes following robotic hepatectomy in this cohort and found the oncologi-
cal outcomes to be comparable. Two of these studies compared robotic surgery to 
open resection and reported a similar 3 year disease free rate at 64% (Lim et al) and 
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72% (Chen et al). The overall 3 year survival rate was approximately 98% and 93% 
[36, 37]. The remaining study compared the oncological outcomes between robotic 
and laparoscopic resections and reported the 5 year disease free and overall survival 
rate at 42% and 65% respectively [5].
4.2 Colorectal liver metastases (CRLM)
Seven studies have examined the oncological outcomes from robotic hepatec-
tomy for colorectal liver metastases. A 100% R0 resection rate was reported by 5 of 
the 7, whilst the remaining 2 studies reported a rate of 92% and 73.7% [23, 38–43]. 
A single study evaluated longer term oncological outcomes, and in a propensity 
matched comparison to laparoscopic resections, reported equivalent 5 year disease 
free and overall survival rates at 38% and 61% respectively [43]. Matched com-
parisons of long term oncological outcomes between open and robotic surgery are 
awaited.
4.3 Cholangiocarcinoma (CAA)
Minimally Invasive Surgery utilising a robotic approach should theoretically 
convey the significant advantages to hilar CCA resections given the necessity of 
extreme precision and micro-anastomosis formation. However CCA resections 
form less than 10% of robotic liver surgery in the current literature, likely due to 
the required tertiary level of surgical expertise and robotic technology [22]. As 
such, the literature exploring oncolocological outcomes is very limited. The largest 
case series (48 patients) of patients undergoing robotic resections for Type I, II 
and III CCA, reported successful lymphadenectomy from stations 7,8,9, 12 and 13 
and an R0 resection rate of 72.9% [44]. A single study has reported on longer term 
outcomes following robotic resections and demonstrated significantly higher rates 
of recurrence and peritoneal disease when compared to a contemporaneous group 
of open resections in the same centre [45]. As such whilst technically feasible and 
safe in expert hands, further studies are required to fully elucidate the oncological 
equivalence of robotic MIS for CCA.
4.4 Gallbladder Cancer
When compared to open radical cholecystectomy, the robotic approach has 
been shown to result in analogous operative times, blood loss, and length of stay. 
Specialist centres have also reported equivalent lymph node yields and demon-
strated the feasibility of complete robotic lymphadenectomy of stations 8,9 12 and 
13 [46–48]. An 100% R0 resection rate has been reported by the only 2 studies that 
present oncological outcomes [47, 48]. To date, no studies have yet to report on 
longer term oncological data following robotic radical cholecystectomy.
5. Limitations
As with other subspecialties of surgery, while the robotic approach can confer 
major operative advantages, limitations also exist and it is important to consider 
these closely, not only for assessment of robotic feasibility, but also in order to adopt 
adoptions of solutions to such limitations.
The initial purchase of robotic systems poses a major financial outlay to health-
care institutions. With many health systems facing unprecedented pressures, such 




robotic models, as well as requirement for further robotic systems associated with a 
growing surgical evidence base will add to financial expense.
Such upfront costs may make the financial case for initial investments difficult 
in a publicly funded health care system such at the UK National Health Service. 
However, as with all technology, costs of equipment have already been seen to 
decrease in older models, while newer designs remain at the top of the market. In 
the same way that laparoscopic stacks and equipment, initially considered a major 
investment, are now considered as standard in any theatres inventory (albeit with 
differing quality across healthcare institutions) robotic theatre systems are likely to 
become common place in the operating theatre complex.
Furthermore, while the earliest days of robotic surgery, saw one company at 
the forefront of robotic design and technology, maintain a virtual monopoly on 
the robotic equipment, market competitors have already emerged, a trend which 
looks set to continue. This is highly likely to bring about a reduction in costs. In this 
context however, it cannot be assumed that an evidence base for robotic surgery 
built on one robotic system is necessarily transferable to different systems, and care 
must be taken when applying this evidence and making financial decisions regard-
ing newer market technology.
In a manner not dissimilar to the initial uptake of laparoscopic minimally inva-
sive surgery in the twentieth century, the uptake of robotic surgery within hepato-
biliary surgery has not been as marked as within other surgical specialties. However, 
this may confer an advantage in financial terms, where robots already purchased 
and present in theatres based on an early uptake in other specialties can be utilised 
for education and training in less robotically advanced surgical specialities.
Another disadvantage posed in much of the literature, in both major and minor 
liver resections is increased operative time, although the clinical maxim “surgical 
time in measured in inpatient days, not theatre minutes” may be prescient here. 
Whilst theatre time is a precious financial resource, particularly in an era of unprec-
edented surgical waiting lists, reduced critical care and overall inpatient stays could 
confer an overall institutional financial advantage.
Length of surgical theatre time is multifactorial. Technical learning curves 
of individual surgeons, which have previously shown to be flatter than that of 
laparoscopic surgery, show operating times inversely proportion to training and 
experience, as expected with any new skill set [49]. Furthermore, overall operating 
theatre time not only encompasses the primary surgical procedure, but also robotic 
system set up, patient positioning, robot docking, and additional tasks performed 
by the theatre team as a whole. In a similar fashion to the primary surgeon activity 
discussed above, the increased experience of adequately trained and well drilled 
theatre team can be expected to significantly reduced theatre times, allowing an 
increased case load for theatre lists.
While every surgical speciality performs unique technical tasks requiring 
specific equipment, liver surgery, to perhaps a greater extent than other forms 
of abdominal surgery, utilise a cornucopia of specific tools not common to other 
subspecialties. Ultrasonic probes, used for intra operative identification of specific 
lesion, hepatobiliary specific energy devices and minimally invasive articulated 
retractors, as well as ultrasonic surgical aspirators, which allow cavitation and 
aspiration of hepatocytes whilst sparing vascular and biliary structures, are not 
yet incorporated into standard robotic systems. This technology, however, already 
exists within the minimal access domain of laparoscopic surgery, so incorporation 
into robotic systems should not pose an insurmountable barrier.
An often described limitation of MIS is the relative lack of tactile feedback pres-
ent in open surgery, making dissection of difficult but vital structures significantly 
more challenging, with potential for catastrophic tissue damage from excessive 
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forces. While much comment was made on this in the advent of laparoscopic 
surgery, the degree of tactile feedback offered in early robotic surgery systems was 
even less. Hydraulic haptic feedback systems are, however, already in development 
with in vivo trials showing significant grip strength reduction more akin to that in 
open surgery [50, 51].
As with any novel surgical technology, it is necessary to temper adoption of 
technology with strict clinical governance to maximise patient safety. This includes 
inclusion of robotics cases in morbidity and mortality discussions, a forum for 
discussing serious untoward events and near misses, and strategies within scientific 
literature to avoid publication bias.
Obesity has become an epidemic in many parts of the western world and 
extremes of BMI offer difficulties in many aspects of surgical practice. While a 
number of studies in other surgical subspecialties have shown the robotic approach 
not to offer significantly worsened outcomes in extremes of BMI, hepatobiliary 
surgery offers specific challenges with non alcoholic fatty liver disease, steatohepa-
titis and liver cirrhosis associated with morbid obesity [52–54].
A recently published US study examined the effects of BMI, prospectively 
observing outcomes in patient subgroups of BMIs <25, 25-35 and > 35, found no 
significant differences found in operative blood loss, operative time of length of 
stay [55]. With a relatively small number of patients in this study however, more 
work is required to accurately identify the possible difficulties or benefits posed 
with hepatic robotic surgery in the obese patient cohort.
Operative training is a vital part of any health service in order to provide future 
surgeons adequate experience and competence to take on standard as well as 
challenging cases with a minimal access approach. While early adopters of robotic 
surgery are often consultant surgeons with strong minimal access laparoscopic 
practice, for these enthusiasts to become robotic trainers themselves takes time 
for building of robotic experience. It is therefore expected that robotic training for 
surgeons in formal training stages will take time to diffuse down, as with the uptake 
of any new surgical practice. However, flatter learning curves with robotic surgery, 
with dual operator consoles and built-in simulation trainer modules to robotic 
surgical systems can offer clinical and non-clinical based training experience. These 
opportunities will increase with a corresponding increasing prevalence of robotic 
systems within healthcare institutions.
6. Future outlook
While limitations within robotic hepatic surgery exist, the future outlook for 
incorporation of robotics into liver surgery, with additional integration of other 
technology offers exciting promise.
Robotics systems, with the primary operator working from a non-sterile sta-
tion with a visual screen, already offers the opportunity to consult pre-operative 
imaging for comparison to intra operative findings. Infrared fluorescence technol-
ogy, incorporated into robotics systems, offers visualisation of vital biliary and 
vascular structures with near fluorescence of indocyanin green. This poses a major 
advantage during dissection of the liver hilar structures, where anatomical varia-
tion is commonplace and iatrogenic injury can prove catastrophic. With constantly 
improving imaging and artificial intelligence technology, it is not difficult to 
imagine intraoperative overlay of imaging to on screen anatomical structures allow-
ing real-time surgical decision making, such as lymph node dissection or surgical 
resection margins. With the rise of artificial intelligence integrated into robotic 
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structures or predefined areas within resection margins could be predefined as “no 
go areas” during operative intervention offering intraoperative artificial intelligence 
guidance to the operating surgeon. It is perhaps even conceivable that automated 
robots could perform hepatic resections, with the primary surgeon adopting a 
supervisory role.
While questions are understandably raised regarding the early stages of surgical 
training on robotic systems, telecommunications incorporated into robotic systems 
can arguably vastly improve training in the latter stages. With shared access, real 
time intra-operative images could be viewed on technology outside of the operating 
theatres allowing recommendations from experienced colleagues in the event of 
intraoperative uncertainty. Indeed, it is conceivable the operative control could be 
managed at work-stations distant to the immediate operating theatre.
Perhaps the most important aspect of the future of robotic surgery, however, 
will be widespread inclusion into standard surgical practice. If robotic surgery is 
to exist outside of a few specialist centres, a balance must be struck between using 
robotics for the most complex technical cases, where a clear evidence base exists 
within the literature, and the everyday use of the robotic system, allowing not 
only the operating surgeon but also whole team to become at home managing and 
trouble-shooting issues that arise with all technology. While major advantages of 
routine use of robotic technology for, for example, minimally invasive cholecys-
tectomy will be difficult to evidence, adoption of such technology on a day-to-day 
basis will be essential for surgical training.
7. Conclusion
Robotic liver surgery is rapidly evolving. There is growing evidence suggesting 
this approach to be feasible and safe. This evidence however is limited to highly 
specialised centres and cannot be consider standard of care. Robotic liver surgery 
shares the advantages of laparoscopic liver surgery and both should be developed in 
parallel to promote wider access to minimally invasive surgery for patients undergo-
ing liver resections. Certain limitations remain whilst there is a promising future of 
innovation and research for robotic liver surgery.
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